| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/08/2005 | EP1536822A1 Stable pharmaceutical composition comprising erythropoietin |
| 06/08/2005 | EP1536821A1 Inhibition of t cell activation by butyrophilin 4 or b7-l1 |
| 06/08/2005 | EP1536819A2 Use of rom production and release inhibitors to treat and prevent intraocular damage |
| 06/08/2005 | EP1536818A2 Fibrinogen binding moieties |
| 06/08/2005 | EP1536817A1 Growth hormone-releasing peptides in the treatment of prevention of atherosclerosis and hypercholesterolemia |
| 06/08/2005 | EP1536816A2 Amelioration of effects of cigarette smoke |
| 06/08/2005 | EP1536813A2 Compositions and methods comprising protein activated receptor antagonists |
| 06/08/2005 | EP1536808A2 Heterocarpin, a plant-derived protein with anti-cancer properties |
| 06/08/2005 | EP1536807A2 Non-polymeric hematopoietic cell clots for delivery of active agents |
| 06/08/2005 | EP1536804A2 2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
| 06/08/2005 | EP1536801A2 Topical compositions and methods for treatment of adverse effects of ionizing radiation |
| 06/08/2005 | EP1536781A1 Nutritional or pharmaceutical compositions for increasing the creatine response of organisms |
| 06/08/2005 | EP1536778A2 Proteins binding to cross-beta structure comprising amyloid and methods for detection and modulation of the cross-beta structure, its formation and its associated toxicity |
| 06/08/2005 | EP1536769A2 Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs |
| 06/08/2005 | EP1536763A2 Depigmenting composition for the skin comprising adapalene and at least one depigmenting agent |
| 06/08/2005 | EP1536753A1 Method for protecting and for modulating dermal-epidermal junctions |
| 06/08/2005 | EP1536689A2 Gene therapy for critical limb ischemia with wild type or mutant enos |
| 06/08/2005 | EP1536688A2 Mammalian megakaryocyte progenitor cell |
| 06/08/2005 | EP1490506A4 Method for generating primate trophoblasts |
| 06/08/2005 | EP1252133B1 Pharmaceutical compounds |
| 06/08/2005 | EP1231925B1 Method and composition for the treatment of adenoviral ocular infections |
| 06/08/2005 | EP1223971B1 Compositions for preventing and treating transplant rejection |
| 06/08/2005 | EP1206488B1 Method for isolating and purifying grass pollen allergens |
| 06/08/2005 | EP1169441B1 Pharmaceutical compositions for the treatment of heart failure |
| 06/08/2005 | EP1024806B1 Use of non-immunosuppressive compounds for promoting nerve regeneration |
| 06/08/2005 | EP0997152B1 Antibodies as REMEDIES FOR LYMPHOCYTIC TUMORS (EXCEPT MYELOMA) |
| 06/08/2005 | EP0960128B1 Gene product over expressed in cancer cells |
| 06/08/2005 | EP0850252B1 Mutant plasminogen activator-inhibitor type 1 (pai-1) and uses thereof |
| 06/08/2005 | EP0793504B1 Chimeric cytokines and uses thereof |
| 06/08/2005 | EP0784471B1 Multi-faceted method to repress reproduction of latent viruses in humans and animals |
| 06/08/2005 | EP0777738B1 Condii toxoplasma p30 expression cassette |
| 06/08/2005 | CN1625603A Genetic polymorphisms in the preprotachykinin gene |
| 06/08/2005 | CN1625566A Lactoferrin |
| 06/08/2005 | CN1625564A Tolerogenic peptides from myelin basic protein |
| 06/08/2005 | CN1625553A Treatment of male sexual dysfunction |
| 06/08/2005 | CN1625398A A combination treatment for acute myocardial infarction |
| 06/08/2005 | CN1625397A Controlled release pharmaceutical dosage forms of a cholesteryl ester transfer protein inhibitor |
| 06/08/2005 | CN1625391A Cyclosporin-containing sustained release pharmaceutical composition |
| 06/08/2005 | CN1625390A Multi-stage oral drug controlled-release system |
| 06/08/2005 | CN1625374A Device for mixing and/or injection cement |
| 06/08/2005 | CN1625338A Method for reducing calcified plaque buildup and cellular malfunction and for balancing ionic calcium |
| 06/08/2005 | CN1624128A Death domain containing receptor 5 antibodies |
| 06/08/2005 | CN1624126A Ret ligand (retl) for stimulating neural and renal growth |
| 06/08/2005 | CN1624115A Cell surface molecule mediating cell adhesion and signal transmission |
| 06/08/2005 | CN1623600A Inhibitor of angiotensin I transferase activity and its application |
| 06/08/2005 | CN1205336C Novel ribozyme of specificity cutting survivin, its medicinal composition and use |
| 06/08/2005 | CN1205335C Tumor death induction ligand gene, gene expression protein and is preparation method |
| 06/08/2005 | CN1205248C Biodegradable poly(alkylene oxide)-poly cp-dioxanone) block polymer soluble in organic solvents, and drug delivery composition comprising same |
| 06/08/2005 | CN1205226C Mouse interleukin-17 receptor sample protein, and coding gene and use thereof |
| 06/08/2005 | CN1205225C Human protein with cancer inhibiting function and its coding sequence |
| 06/08/2005 | CN1205224C Nacre substrate protein, coding gene and cloning method and application thereof |
| 06/08/2005 | CN1205222C Method for isolating and purifying grass pollen allergens |
| 06/08/2005 | CN1205221C 修饰的凝血因子Ⅷ Modified coagulation factor Ⅷ |
| 06/08/2005 | CN1205220C Novel cyclosporins |
| 06/08/2005 | CN1205186C ACE inhibitor nitric salts |
| 06/08/2005 | CN1204924C Liquid composition of biodegradable block copolymer for drug delivery system and process for preparation thereof |
| 06/08/2005 | CN1204921C Solution preparations stabilized over long time |
| 06/08/2005 | CN1204920C Antifungal medicnie synergist and its prepn and application |
| 06/08/2005 | CN1204919C Long-acting intra-ocular release system of cyclosporin |
| 06/08/2005 | CN1204893C Pharmaceutical composition |
| 06/07/2005 | US6904369 For drug screening stem cell factor (SCF) binding peptides; genetic engineering; crystal structure |
| 06/07/2005 | US6903244 For screening drugs for treatment of atherosclerosis and hypertension |
| 06/07/2005 | US6903204 Polynucleotides encoding methionyl tRNA synthetase from Staphylococcus aureus, related products and methods |
| 06/07/2005 | US6903203 Immunoglobulin for use in the diagnosis and therapy of cancer |
| 06/07/2005 | US6903195 Obtaining a cell sample, lysing or permeabilizing the cells to antibodies, adding antibody to the cell sample, complexing antibody with CDN-1(a protein) and detecting the CDN protein |
| 06/07/2005 | US6903194 Antibody against human parathormone related peptides |
| 06/07/2005 | US6903189 Polypeptide for use in the treatment of cancer, arthritis, psoriasis and diabetes |
| 06/07/2005 | US6903188 Isolated functional derivative of an Mts protein that is preferably a multimeric protein complex. |
| 06/07/2005 | US6903187 Structural modification of clostridal neurotoxins including addition or deletion of a leucine-based motif to treat biological disorders include treating autonomic disorders, neuromuscular disorders and pain |
| 06/07/2005 | US6903186 Analogues of GLP-1 |
| 06/07/2005 | US6903185 Generating chimeric zinc finger protein; obtain nucleotide sequences coding chimeric protein, transform cells, express nucleotide sequences, recover protein |
| 06/07/2005 | US6903184 Multiple antigenic peptides immunogenic against Streptococcus pneumonia |
| 06/07/2005 | US6903183 Specific polypeptide, useful for treatment of steroid hormone-dependent disorders, in particular, for lipoid congenital adrenal hyperplasia |
| 06/07/2005 | US6903135 Methods and products related to 16-HETE analogs |
| 06/07/2005 | US6903131 Administering to a patient an antiangiogenesis or anticancer agent (N,N-disubstituted-3,4-diamino-2,4-dione-pyrroline derivatives for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer |
| 06/07/2005 | US6903128 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 06/07/2005 | US6903127 Sexual disorders |
| 06/07/2005 | US6903121 Treatment of tumors with acetylenes disubstituted with a phenyl or heteroaromatic group and a substituted chromanyl, thiochromanyl or tetrahydroquinolinyl group in combination with other anti-tumor agents |
| 06/07/2005 | US6903100 Administering methotrexate at high level to cross the blood brain barrier; methotrexate administration is accompanied by leucovorin rescue of the periphery |
| 06/07/2005 | US6903088 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 06/07/2005 | US6903081 Phosphoramidates and methods therefor |
| 06/07/2005 | US6903078 Applying wound healing agents comprising nucleotide sequences codes for platelet derived growth factors(PDGF), keratinocyte growth factors(KGF), insulin like growth factors(IGF) and insulin like growth factor binding proteins(IGFBP) |
| 06/07/2005 | US6903075 Fibronectin antagonists such as N-(3,4-dimethoxybenzene-sulfonyl)-1,2,3,4-tetrahydroisoquinoline-3(S) -carbonyl-(L)-leucine, used for prophylaxis asthma, allergies, inflammation, multiple sclerosis and autoimmune disorders |
| 06/07/2005 | US6903074 Cyclic polypeptides having high receptivity and selectivity for neurokinins and hormones, admininstered for prophylaxis of gastrointestinal disorders or cancers |
| 06/07/2005 | US6903073 Methods to stimulate insulin production by pancreatic beta-cells |
| 06/07/2005 | US6903072 Polypeptide for use in the treatment of wounds, liver, inflammatory, kidney, lung and viral disorders |
| 06/07/2005 | US6903071 Cartilage/bone inducing materials for reparation |
| 06/07/2005 | US6903070 Mixtures of peptide antibiotics and cyclodextrins used for prophylaxis of bacterial infections in humans |
| 06/07/2005 | US6903069 Factor VII glycoforms |
| 06/07/2005 | US6903068 Immunology and cell proliferation modulation using peptides, polypetides or proteins comprising colostrum |
| 06/07/2005 | US6902932 Helically organized silk fibroin fiber bundles for matrices in tissue engineering |
| 06/07/2005 | US6902910 Death domain containing receptor 4 |
| 06/07/2005 | US6902893 Lyme disease vaccines |
| 06/07/2005 | US6902888 Diabetes gene |
| 06/07/2005 | US6902885 For detecting viral and cellular polypeptide interactions |
| 06/07/2005 | US6902744 Exendin agonist formulations and methods of administration thereof |
| 06/07/2005 | US6902743 For immunization against enterotoxigenic escherichia; immunotherapy; sustained release; immunoassay |
| 06/07/2005 | US6902738 Topical oral dosage forms containing bismuth compounds |
| 06/07/2005 | US6902735 Antibodies to human IL-17F and other CTLA-8-related proteins |
| 06/07/2005 | US6902734 Also an IL-12 anti-idiotype antibody to the antibody |